http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-T55989-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b9f373878f16dc291ff597162e9b344
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-13
filingDate 1990-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1af07a1b6adb8fefd828858218041bf2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6693729e3c46fc22e52c20f06b6bc026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8279ce11c4fb389bdb96a8667d01361d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15b16bf0b25af68e35b4e1a029b4edbf
publicationDate 1991-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-T55989-A
titleOfInvention Process for producing pharmaceutical compositions containing n-imidazolyl derivatives of bicyclic compounds in a given case with cyclosporins
abstract The invention relates to the use of N-imidazolyl derivatives of bicyclic compounds of general formula (I), wherein (a) compound alpha is (II) wherein Y completes a single bond or is oxygen or a -CH2- group and the symbol --- represents a single or double bond or (b) compound alpha is (III) and the symbol --- represents a double bond; one of R1, R2, R3 and R4 is -CH2OH, C2-C4 acyl, (IV), -COOR7, -CH2COOR7, (V), (VI) or (VII) in which each of R7, R8 and R9 is independently hydrogen or C1-C4 alkyl, and the others are independently chosen from hydrogen, hydroxy, halogen, C1-C4 alkyl, C1-C4 alkoxy and -COOR7 wherein R7 is as defined above; and one of R5 and R6 is hydrogen and the other is hydrogen, C1-C6 alkyl or phenyl; or a pharmaceutically acceptable salt thereof, in particular in combination with cyclosporin A. The compounds obtained are useful in preventing and/or treating cyclosporin A-induced nephrosis in mammals.
priorityDate 1989-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416221902
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4329331
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70373078
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53824222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22227373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54224476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420427886
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584148
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19840463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416221905
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416221906
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3021570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419764321
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415728431
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3021566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451822344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416221904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426067522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3021568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6847
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56009
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411174055
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454185321
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415816644
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419764322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457830924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451709273
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22483
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3021569

Total number of triples: 71.